FindTrial
Sign In

Development and Application value Evaluation of Application Software (APP) for Regulating Blood Glucose and Insulin in Critically Ill Patients

Development and Application value Evaluation of Application Software (APP) for Regulating Blood Glucose and Insulin in Critically Ill Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056238
Enrollment
Unknown
Registered
2022-02-02
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperglycemia, critically ill patient

Interventions

Experimental group:use Application Software (APP)
Blank group:use paper-based insulin protocol

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Critically ill patients aged >= 18 years; 2. Patients with blood glucose >= 15mmol/L, who need insulin micropump to control blood glucose; 3. Estimated length of ICU stay >= 3 days.

Exclusion criteria

Exclusion criteria: 1. Refusing to participate in the experiment; 2. Eetoacidosis, hyperosmotic hyperglycemia syndrome, chronic pancreatitis; 3. End-stage of diseases.

Design outcomes

Primary

MeasureTime frame
Blood glucose;—

Countries

China

Contacts

Public ContactYu Huijie

The First Hospital of Jiaxing

yhjtj88@sina.com+86 13957328742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026